Etaluma Funding: How Much Did They Raise & Key Investors

How Much Did Etaluma Raise?
Funding & Key Investors

Etaluma, a San Diego-based pioneer in bio-imaging technology, has successfully secured a significant capital injection, bringing its total capitalization to $131K. This latest financing round, which accounts for $131K, underscores the company's robust market position as it scales its proprietary imaging ecosystem. By leveraging this strategic investment, Etaluma is well-positioned to accelerate the deployment of its high-resolution, compact microscopy solutions across global life science research markets.

The infusion of capital marks a pivotal moment for the firm, transitioning from its foundational development phase into a period of aggressive commercial expansion. As the demand for sophisticated, incubator-compatible live cell imaging tools continues to rise, Etaluma's ability to provide near diffraction-limited resolution in a compact form factor remains a key competitive differentiator in the highly specialized bio-instrumentation sector.

What is Etaluma?

Etaluma

Manufacturing

Test & Measurement Equipment

Medical Devices & Equipment

Founded in 2009, Etaluma has established itself as a critical player in the bio-imaging landscape by simplifying the complexities of fluorescence microscopy. The company specializes in an integrated ecosystem that combines advanced sensors, precision illumination, and intuitive software to deliver high-sensitivity imaging. Its core product line, which includes compact microscopes and modular imaging components, is engineered for seamless integration into environmental chambers and OEM instruments. By prioritizing solid-state optics and zero pixel shift technology, Etaluma enables researchers to conduct high-fidelity live cell imaging without the constraints of traditional, bulky laboratory equipment. This technological focus positions the company at the intersection of optical engineering and cellular biology, serving a diverse clientele ranging from academic research institutions to commercial diagnostic developers.

How much funding has Etaluma raised?

Etaluma has raised a total of $131K across 1 funding round:

2021

Debt

$131K

Debt (2021): $131K with participation from PPP

Key Investors in Etaluma

PPP

Public-Private Partnership

What's next for Etaluma?

With the recent influx of capital, Etaluma is poised to deepen its penetration into the life sciences market by scaling its manufacturing capabilities and expanding its OEM partnership network. The strategic roadmap likely involves enhancing the software suite to support automated data analysis, a critical requirement for modern high-throughput screening environments. Furthermore, the company is expected to leverage its current financial standing to bolster its R&D efforts, focusing on next-generation sensor integration to maintain its technological edge. As the industry shifts toward more integrated, automated laboratory workflows, Etaluma's compact, high-performance imaging modules are uniquely suited to meet the evolving needs of the biotech and pharmaceutical sectors, ensuring sustained growth and long-term value creation for its stakeholders.

See full Etaluma company page

See More Financial Insights